North America Antimicrobial Coating for Medical Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America antimicrobial coating for medical device market size is expected to reach US$ 2,596.40 million by 2031 from US$ 1,190.37 million in 2024. The market is estimated to record a CAGR of 12.2% from 2025-2031.

Executive Summary and North America Antimicrobial Coating for Medical Device Market Analysis:

HAIs may occur in all types of healthcare settings, including ambulatory surgical centers, dialysis facilities, acute care hospitals, outpatient care (e.g., physicians' offices and healthcare clinics), and long-term care facilities (e.g., nursing homes and rehabilitation facilities). As per the US Department of Health and Human Services, 1 out of every 25 hospitalized patients is affected by an HAI at any time in the US. In American hospitals alone, the Centers for Disease Control (CDC) estimated that HAIs account for an estimated 1.7 million infections and 99,000 associated deaths yearly in the country. Therefore, the rising prevalence of HAIs underlines the need for developing medical devices with antimicrobial coatings in North America, thereby bolstering the antimicrobial coatings for medical devices market growth. The US, Canada, and Mexico are the prime contributors to the market in North America.

North America Antimicrobial Coatings for Medical Devices Market: Strategic Insights

North America Antimicrobial Coating for Medical Device Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial coating for medical device market analysis are material, coating type, device type, application, and end use.

• By material, the antimicrobial coating for the medical device market is bifurcated into metallic coatings and non-metallic coatings. The metallic coatings segment held a larger share of the market in 2024.

• By coating type, the antimicrobial coating for the medical device market is segmented into antibacterial coatings, antiviral coatings, and others. The antibacterial coatings segment held the largest share of the market in 2024.

• By device type, the antimicrobial coating for the medical device market is segmented into catheters, implantable devices, surgical instruments, and others. The implantable devices segment held the largest share of the market in 2024.

• By application, the antimicrobial coating for the medical device market is segmented into general surgery, cardiovascular, orthopedics, gynecology, dentistry, and others. The cardiovascular segment held the largest share of the market in 2024.

• By end user, the antimicrobial coating for the medical device market is segmented into medical device manufacturers, contract manufacturers, and service providers. The medical device manufacturers segment held the largest share of the market in 2024.

North America Antimicrobial Coatings for Medical Devices Market Players Density: Understanding Its Impact on Business Dynamics

The North America Antimicrobial Coatings for Medical Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Antimicrobial Coating for Medical Device Market Outlook

Hospital-acquired/healthcare-associated infections (HAIs) encompass catheter-associated urinary tract infections (CAUTI), central line-associated bloodstream infections, and ventilator-associated pneumonia. These infections can also arise at surgical sites, known as surgical site infections (SSIs). HAIs impose a significant economic burden on the healthcare system.

HAIs present a major challenge in the delivery of health services and are among the most frequent adverse events that patients encounter. On average, about 1 in 10 patients may experience such infections globally, with the incidence rising sharply in low- and middle-income countries, as well as among vulnerable groups, particularly those in intensive care units.

As Per a 2023 study conducted by Balasubramanian et al., almost 136 million cases of HAI/AR occur every year across the globe. Further, 63.5% of these infections are associated to the health care setting. The impact on global health is significant, with estimates suggesting that in 2019, over 5 million deaths were connected to antimicrobial resistance.

According to the US Department of Health and Human Services, the increasing prevalence of HAIs, which affect 1 in 31 hospitalized patients, along with a growing emphasis on infection control, is driving the demand for advanced antibacterial solutions. Further, the Centers for Disease Control and Prevention (CDC) lists CAUTIs among the most common HAIs. CAUTIs are linked to increased morbidity, mortality, healthcare costs, and longer hospital stays. As per the CDC, 15-25% of hospitalized patients receive urinary catheters during their stay, which are associated with approximately 75% of UTIs acquired in hospitals. The use of antibacterial coatings on catheters can help reduce the incidence of these infections by inhibiting bacterial colonization.

The increasing awareness of infection control, a rise in the number of surgical procedures, and the growing prevalence of chronic diseases that often require catheterization in patients bolster the antibacterial coatings for medical devices market growth.

North America Antimicrobial Coating for Medical Device Market Country Insights

Based on country, the North America antimicrobial coating for medical device market comprises the US, Canada, and Mexico. The US held the largest share in 2024.

HAIs are a major concern in healthcare facilities in the US, leading to longer hospital stays and increased mortality. Device-associated HAIs (DA-HAIs), such as ventilator-associated pneumonia (VAP), central-line-associated bloodstream infections (CLABSI), and catheter-associated urinary tract infections (CAUTI), cause a significant number of these infections. According to an article published in the Research and Reports in April 2022, up to 80% of complicated urinary tract infections are linked to indwelling urinary catheters in the US. CAUTIs are the most common type of HAIs, accounting for approximately 1 million cases annually in the US. They are also the leading cause of secondary bloodstream infections. Additionally, 3-10% of residents in long-term care facilities are managed with chronic indwelling catheters. The growing use of such catheters may increase the demand for antimicrobial coatings for catheters to prevent CAUTIs.

North America Antimicrobial Coating for Medical Device Market Company Profiles

Some of the key players operating in the market include The Sherwin-Williams Co, PPG Industries Inc, CytaCoat AB, Covalon Technologies Ltd, Koninklijke DSM NV, Specialty Coating Systems Inc., AST Products Inc, Hydromer Inc, BioInteractions Ltd, and Spartha Medical SAS, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Antimicrobial Coating for Medical Device Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.

• Industry trade journals and other relevant publications.

• Government documents, statistical databases, and market reports.

• News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.

• Enhance the expertise and market understanding of the analysis team.

• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers

• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise